TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Reviva Bio AB
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
3,534
|
1,566
|
1,040 |
| Financial expenses |
10
|
1
|
0 |
| Earnings before taxes |
711
|
123
|
105 |
| EBITDA |
795
|
132
|
112 |
| Total assets |
2,101
|
1,109
|
603 |
| Current assets |
1,450
|
1,081
|
578 |
| Current liabilities |
610
|
552
|
128 |
| Equity capital |
1,090
|
495
|
413 |
| - share capital |
5
|
4
|
4 |
| Employees (average) |
19
|
11
|
8 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
51.9%
|
44.6%
|
68.5% |
| Turnover per employee |
186
|
142
|
130 |
| Profit as a percentage of turnover |
20.1%
|
7.9%
|
10.1% |
| Return on assets (ROA) |
34.3%
|
11.2%
|
17.4% |
| Current ratio |
237.7%
|
195.8%
|
451.6% |
| Return on equity (ROE) |
65.2%
|
24.8%
|
25.4% |
| Change turnover |
1,856
|
564
|
120 |
| Change turnover % |
111%
|
56%
|
13% |
| Chg. No. of employees |
8
|
3
|
0 |
| Chg. No. of employees % |
73%
|
38%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.